Publications for Annelie Abrahamsson
Co-author map based on ISI articles 2007-

Publications mentioned in social media 15 times*

Keywords

women vivo vegf tumors tissue tamoxifen levels leptin il-1 human extracellular estrogen estradiol diet cells cancer breast angiogenin angiogenesis adiponectin

Journal Articles

Vivian Morad, Annelie Abrahamsson, Preben Kjölhede and Charlotta Dabrosin
  Adipokines and Vascular Endothelial Growth Factor in Normal Human Breast Tissue in Vivo - Correlations and Attenuation by Dietary Flaxseed
 
Altmetric usage: 2

  Journal of mammary gland biology and neoplasia, 2016, 21(1-2), 69-76.
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Ameet K. Mishra, Annelie Abrahamsson and Charlotta Dabrosin
  Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ER alpha positive breast cancer by up-regulation of ER beta
  OncoTarget, 2016, 7(35), 56876-56888.

Annelie Abrahamsson, Anna Rzepecka, Thobias Romu, Magnus Borga, Olof Dahlqvist Leinhard, Peter Lundberg, Johan Kihlberg and Charlotta Dabrosin
  Dense breast tissue in postmenopausal women is associated with a pro-inflammatory microenvironment in vivo
  Oncoimmunology, 2016, 5(10), .

Annelie Abrahamsson and Charlotta Dabrosin
  Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo
  OncoTarget, 2015, 6(26), 22959-22969.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Susanne Svensson, Annelie Abrahamsson, Gabriela Vazquez Rodriguez, Anna-Karin Olsson, Lasse Jensen, Yihai Cao and Charlotta Dabrosin
  CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
 
Altmetric usage: 3

  Clinical Cancer Research, 2015, 21(16), 3794-3805.
 Web of Science® Times Cited: 13

Vivian Morad, Annelie Abrahamsson and Charlotta Dabrosin
  Estradiol Affects Extracellular Leptin: Adiponectin Ratio in Human Breast Tissue in Vivo
  Journal of Clinical Endocrinology and Metabolism, 2014, 99(9), 3460-3467.
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Karin Söderlund, Susanne Svensson, Annelie Abrahamsson, Christina Bendrik, Jennifer Robertson, Jack Gauldie, Anna-Karin Olsson and Charlotta Dabrosin
  Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer
 
Altmetric usage: 2

  Journal of Immunology, 2013, 190(8), 4420-4430.
 Web of Science® Times Cited: 20

Annelie Abrahamsson, Vivian Morad, Niina M Saarinen and Charlotta Dabrosin
  Estradiol, Tamoxifen, and Flaxseed Alter IL-1 beta and IL-1Ra Levels in Normal Human Breast Tissue in Vivo
 
Altmetric usage: 5

  Journal of Clinical Endocrinology and Metabolism, 2012, 97(11), E2044-E2054.
 Web of Science® Times Cited: 11

Gabriel Lindahl, Niina Saarinen, Annelie Abrahamsson and Charlotta Dabrosin
  Tamoxifen, Flaxseed, and the Lignan Enterolactone Increase Stroma- and Cancer Cell-Derived IL-1Ra and Decrease Tumor Angiogenesis in Estrogen-Dependent Breast Cancer
 
Altmetric usage: 2

  CANCER RESEARCH, 2011, 71(1), 51-60.
 Web of Science® Times Cited: 26

Ulrika Nilsson, Niina Saarinen, Annelie Abrahamsson, Tarja Nurmi, Sofia Engblom and Charlotta Dabrosin
  Tamoxifen and Flaxseed Alter Angiogenesis Regulators in Normal Human Breast Tissue In Vivo
 
Altmetric usage: 1

  PLoS ONE, 2011, 6(9), .
   Fulltext  PDF  
 Web of Science® Times Cited: 15

Ulrika Nilsson, Annelie Abrahamsson and Charlotta Dabrosin
  Angiogenin Regulation by Estradiol in Breast Tissue: Tamoxifen Inhibits Angiogenin Nuclear Translocation and Antiangiogenin Therapy Reduces Breast Cancer Growth In vivo
  Clinical Cancer Research, 2010, 16(14), 3659-3669.
 Web of Science® Times Cited: 21

Niina M. Saarinen, Annelie Abrahamsson and Charlotta Dabrosin
  Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo
  International Journal of Cancer, 2010, 127(3), 737-745.
 Web of Science® Times Cited: 17

Conference Articles

N M Saarinen, Annelie Abrahamsson and Charlotta Dabrosin
  Enterolactone but not genistein decreases estradiol-induced tumor growth, angiogenesis, and secreted VEGF in vivo in human breast cancer. in CANCER RESEARCH, vol 69, issue 2, pp 325S-325S
  CANCER RESEARCH, 2009.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.